Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis

Shah, Neil P. ; Lee, Francis Y. ; Luo, Roger ; Jiang, Yibin ; Donker, Marjolein ; Akin, Cem

Blood, 2006-07, Vol.108 (1), p.286-291 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível